Wang, Q; Simpao, A; Sun, L et al. (2001) Contribution of the active metabolite, norcocaine, to cocaine's effects after intravenous and oral administration in rats: pharmacodynamics. Psychopharmacology (Berl) 153:341-52
|
Lau, C E; Sun, L; Wang, Q et al. (2000) Oral cocaine pharmacokinetics and pharmacodynamics in a cumulative-dose regimen: pharmacokinetic-pharmacodynamic modeling of concurrent operant and spontaneous behavior within an operant context. J Pharmacol Exp Ther 295:634-43
|
Lobarinas, E; Falk, J L (2000) Comparison of benzodiazepines and the non-benzodiazepine agents zolpidem and zaleplon with respect to anxiolytic action as measured by increases in hypertonic NaCl-solution drinking in rats. Psychopharmacology (Berl) 149:176-80
|
Ma, F; Falk, J L; Lau, C E (1999) Cocaine pharmacodynamics after intravenous and oral administration in rats: relation to pharmacokinetics. Psychopharmacology (Berl) 144:323-32
|
Lobarinas, E; Lau, C E; Falk, J L (1999) Sensitization of operant behavior to oral cocaine with increasing- and repetitive-dose regimens. Behav Pharmacol 10:15-26
|
Lau, C E; Wang, Y; Sun, L et al. (1999) Pharmacokinetic determinants of cocaine's differential effects on locomotor and operant behavior. Eur J Pharmacol 381:85-92
|
Falk, J L; Yosef, E; Schwartz, A et al. (1999) Establishing oral preference for quinine, phencyclidine and caffeine solutions in rats. Behav Pharmacol 10:27-38
|
Ma, F; Falk, J L; Lau, C E (1999) Within-subject variability in cocaine pharmacokinetics and pharmacodynamics after intraperitoneal compared with intravenous cocaine administration. Exp Clin Psychopharmacol 7:3-12
|
Falk, J L; Yosef, E; Kuo, C et al. (1999) Establishing preference for lidocaine solution to water: comparison between a fading and an abrupt-removal procedure for withdrawing a compound vehicle. Behav Pharmacol 10:803-8
|
Lau, C E; Ma, F; Foster, D M et al. (1999) Pharmacokinetic-pharmacodynamic modeling of the psychomotor stimulant effect of cocaine after intravenous administration: timing performance deficits. J Pharmacol Exp Ther 288:535-43
|
Showing the most recent 10 out of 25 publications